Warwick Medical School, University of Warwick, Coventry, CV4 7HL, UK.
Interv Neuroradiol. 2024 Jun;30(3):317-325. doi: 10.1177/15910199221107259. Epub 2022 Jun 7.
Transradial access (TRA) is becoming more popular in neurointerventional radiology procedures and has been associated with reduced mortality, morbidity and access site complications. Guidelines state that TRA is a feasible option for posterior circulation thrombectomy however the evidence base is limited and no systematic literature review has yet been undertaken to evaluate its safety and efficacy.
The Cochrane Library, PubMed, Web of Science, Scopus, TRIP and Embase databases were searched. Outcomes collected included TICI scores, puncture to recanalisation time, mRS scores at 90 days and access site complications.
291 records were identified and 31 full text articles were assessed for eligibility. Eight studies met the inclusion criteria and were meta-analysed. The rate of TICI 2b-3 was 94.7% (89.7-99.8% at 95% CI), TICI 3 was 67.9% (42.2-93.6% at 95% CI) and mRS 0-2 at 90 days was 49.8% (31.5-68.1% at 95% CI). Median puncture to reperfusion times were extracted from three studies as 24 (IQR 18-40), 24 (IQR 17.5-56.5) and 27 (IQR 24-33.5) minutes. No access site complications were reported. TICI 2b-3, TICI 3 and mRS scores were comparable to data for transfemoral access (TFA) from a large systematic review. Puncture to recanalisation times appeared lower than the TFA data but statistical comparison of this outcome was not possible.
The use of TRA in posterior circulation thrombectomy is safe and effective with comparable results to TFA. Further research with a larger sample size is required to fully investigate the potential for shortened puncture to recanalisation times.
经桡动脉入路(TRA)在神经介入放射学中越来越受欢迎,与降低死亡率、发病率和入路部位并发症有关。指南指出,TRA 是后循环取栓术的一种可行选择,但其证据基础有限,尚未进行系统的文献综述来评估其安全性和有效性。
检索 Cochrane 图书馆、PubMed、Web of Science、Scopus、TRIP 和 Embase 数据库。收集的结果包括 TICI 评分、穿刺至再通时间、90 天 mRS 评分和入路部位并发症。
共确定了 291 条记录,并对 31 篇全文文章进行了评估以确定其是否符合纳入标准。8 项研究符合纳入标准并进行了荟萃分析。TICI 2b-3 的比例为 94.7%(95%CI 为 99.8%89.7%),TICI 3 的比例为 67.9%(95%CI 为 42.2%93.6%),90 天 mRS 0-2 的比例为 49.8%(95%CI 为 31.5%~68.1%)。3 项研究中提取的中位数穿刺至再灌注时间分别为 24(IQR 18-40)、24(IQR 17.5-56.5)和 27(IQR 24-33.5)分钟。没有报告入路部位并发症。TICI 2b-3、TICI 3 和 mRS 评分与大型系统评价中经股动脉入路(TFA)的数据相当。穿刺至再通时间似乎短于 TFA 数据,但无法对这一结果进行统计学比较。
在后循环取栓术中使用 TRA 是安全有效的,结果与 TFA 相当。需要进一步进行更大样本量的研究,以充分探讨缩短穿刺至再通时间的潜力。